澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

TELIX PHARMACEUTICALS LTD

16.300

+0.4502.84%

成交量：121.39万

成交额：1,974.73万

市值：55.21亿

市盈率：118.90

高：16.500

开：15.950

低：15.840

收：15.850

52周最高：18.220

52周最低：8.260

股本：3.39亿

流通股本：2.75亿

量比：0.86

换手率：0.44%

股息：- -

股息率：- -

每股收益(TTM):0.137

每股收益(LYR):-0.030

净资产收益率：7.36%

总资产收益率：2.71%

市净率：7.88

市盈率(LYR):-537.49

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Profound Medical与Telix Pharmaceuticals达成共同教育协议，推动基于PSMA的前列腺诊疗发展

Telix Pharmaceuticals旗下Illuccix与Gozellix获批用于PSMA阳性前列腺癌病灶PET成像

Telix Pharma股价在ITM交易引发抛售后反弹；花旗支持其增发股份

每日特惠-并购

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/TLX.AU"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":16.3,"timestamp":1791781920000,"preClose":15.85,"halted":0,"volume":1213896,"delay":0,"changeRate":0.02839116719242909,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.13709179024464557,"marketStatus":"未开盘","change":0.45,"latestTime":"10-12 16:12:00 AEDT","open":15.95,"high":16.5,"low":15.84,"amount":19747269,"amplitude":0.04164,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.13709179024464557,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791846000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":15.85,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":0.858302118791885,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":15.85,"auctionPrice":16.3,"auctionVolume":116304,"auction":3,"marketStatus":"盘后竞价","timestamp":1791781810953}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.030326,"volumeRatio":0.858302118791885,"shares":338721355,"dividePrice":0,"high":16.5,"amplitude":0.04164,"preClose":15.85,"low":15.84,"week52Low":8.26,"pbRate":"7.88","psRate":"4.31","week52High":18.22,"institutionHeld":0,"latestPrice":16.3,"eps":0.13709179024464557,"divideRate":0,"volume":1213896,"delay":0,"ttmEps":0.13709179024464557,"open":15.95,"prevYearClose":11.2,"prevWeekClose":15.85,"prevMonthClose":15.72,"prevQuarterClose":15.72,"fiveDayClose":15.55,"twentyDayClose":16.34,"sixtyDayClose":15.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1189105556","title":"Profound Medical与Telix Pharmaceuticals达成共同教育协议，推动基于PSMA的前列腺诊疗发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1189105556","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189105556?lang=zh_cn&edition=fundamental","pubTime":"2026-10-09 19:45","pubTimestamp":1791546340,"startTime":"0","endTime":"0","summary":"Profound Medical与Telix Pharmaceuticals签署共同教育协议，旨在推进以PSMA为导向的前列腺护理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143871061","title":"Telix Pharmaceuticals旗下Illuccix与Gozellix获批用于PSMA阳性前列腺癌病灶PET成像","url":"https://stock-news.laohu8.com/highlight/detail?id=1143871061","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143871061?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 06:23","pubTimestamp":1790720587,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals旗下Illuccix与Gozellix获批用于PSMA阳性前列腺癌病灶PET成像","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669619432","title":"Telix Pharma股价在ITM交易引发抛售后反弹；花旗支持其增发股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669619432","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669619432?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 09:00","pubTimestamp":1790038804,"startTime":"0","endTime":"0","summary":"BUZZ-Telix Pharma股价在ITM交易引发抛售后反弹；花旗支持其增发股份9月22日-** Telix Pharmaceuticals（TLX.AX）股价一度上涨6.8%至16.83澳元，创下自9月15日以来的最大盘中涨幅** 该公司周一股价下跌11.7%，此前 (link)同意以约16.5亿美元（按无现金、无债务基础计算）收购总部位于德国的ITM Isotope Technologie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4S45E01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","BK4566","LU0098860793.USD","LU0130102774.USD","LU1668664300.SGD","LU2462157665.USD","LU2456880835.USD","IYF","LU0648001328.SGD","LU1244550221.USD","LU1506573853.SGD","BK4585","LU0170899867.USD","BK7067","LU2125154935.USD","LU2360032135.SGD","LU1244550494.USD","LU0310800965.SGD","LU1244550577.SGD","LU0162691827.USD","LU1144417596.USD","LU2125154778.USD","LU2236285917.USD","TFNS","LU0130517989.USD","FTXO","LU0320765646.SGD","LU1074936037.SGD","LU0203347892.USD","BK4559","BK4504","IE00BSNM7G36.USD","LU0128525689.USD","LU0203345920.USD","LU1201861249.SGD","LU0477156953.USD","LU1366192091.USD","BK4534","BK4588","LU0106831901.USD","LU2417539215.USD","LU0980610538.SGD","TLX.AU","LU0052756011.USD","LU1267930227.SGD","LU1791807156.HKD","LU0072461881.USD","LU0314106906.USD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159168","title":"每日特惠-并购","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159168","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669159168?lang=zh_cn&edition=fundamental","pubTime":"2026-09-21 19:37","pubTimestamp":1789990660,"startTime":"0","endTime":"0","summary":"每日特惠-并购路透9月21日-截至周一格林尼治标准时间09:30，已报道以下收购要约、合并、收购和资产处置：** 美国烈酒制造商萨泽拉克对饮料公司贝伦岑发起了每股5.55欧元的全面收购要约，该要约已获得贝伦岑监事会和执行董事会的支持。nL8N45D07V** 澳大利亚泰利克斯制药公司TLX.AX表示，已同意以无现金、无债务为基础，以约16.5亿美元收购总部位于德国的ITM Isotope Technologies Munich SE，此举将进一步推动其在放射性药物领域的扩张计划。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4S45D0R6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK0182","BK1190","BK0084","BK0070","600392","BK1513","BK0233","BK7067","00769","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}